Objective: To evaluate directional diffusivities within the optic nerve in a first event of acute optic neuritis to determine whether decreased axial diffusivity (AD) would predict 6-month visual outcome and optic nerve integrity measures.
Arch Neurol. 2012;69 (1) : [65] [66] [67] [68] [69] [70] [71] . Published online September 12, 2011 September 12, . doi:10.1001 September 12, /archneurol.2011 I MAGING SURROGATES THAT PREdict outcome and correlate with function are needed in the study of multiple sclerosis (MS). Although demyelinated white matter plaques are sensitively detected on magnetic imaging resonance (MRI) T2-weighted scans, such sequences do not quantify tissue integrity within lesions. 1, 2 An appreciation of axon and myelin damage may improve our understanding of recovery and prognosis. 3 Diffusion tensor imaging (DTI) offers a potential means to evaluate axon and myelin pathology in MS. Mouse models of central nervous system injury demonstrated that decreasing axial diffusivity (AD; principle eigenvalue, 1 or ) has a histopathologic correlation with axonal loss, and increasing radial diffusivity (mean of 2 and 3 , or Ќ ) correlates with myelin loss. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Also, within animal models, low axial and high radial diffusivities correlate with functional outcome. 14, 15 Human studies that assess the predictive ability of directional diffusivities during acute demyelinating disease have been few. [16] [17] [18] Our study was designed to translate the animal DTI-histopathologic studies to human optic neuritis.
We hypothesized that, in acute optic neuritis, a low AD would predict a worse clinical outcome owing to its association with acute axon damage. The amplitude of visual evoked potentials (VEPs) and the thickness of the retinal nerve fiber layer (RNFL) were included in our study to corroborate this association. This investigation expands on our previous preliminary report of 12 subjects with just 3 months clinical follow-up by including more subjects, longer follow-up with longitudinal analyses, and evaluation of initial AD to 6-month outcomes for VEPs and RNFL thickness.
METHODS

STUDY PROTOCOL AND ENROLLMENT
All subjects provided informed consent, after approval by the Washington University Human Research Protection Office and institutional review board. Six optic nerve MRI scans were obtained over the course of 12 months for all subjects aged 18 to 60 years who presented with acute visual loss consistent with a first demyelinating event of optic neuritis. A baseline MRI scan was performed within 31 days of onset of clinical optic neuritis, first characterized by symptoms of pain, loss of visual acuity, and/or loss of color vision. Study entry within the acute period necessitated enrollment before formal diagnosis was finalized. Study visits were scheduled 2 weeks after the baseline assessment and at 1, 3, 6, and 12 months. All visits included an MRI scan and clinical measures of vision. Optical coherence tomography was performed, and VEPs were obtained, at baseline, 6 months, and 12 months.
Twenty-nine subjects were enrolled, of whom 25 had at least 6 months of follow-up. Three subjects were lost to follow-up before 6 months, and 1 subject did not fit in the MRI scanner. For our study, outcome was defined at 6 months based on a return to normal vision (ie, complete recovery: a visual acuity of Ն0.8, based on the resolution adopted by the International Council of Ophthalmology, 19 and a contrast sensitivity of Ͼ1.60 logMAR, based on the Pelli-Robson contrast sensitivity test 20 ) or incomplete recovery. Twenty-three optic nerves from 21 subjects were also available for 12-month follow-up, but that included 4 optic nerves that were not usable owing to recurrent optic neuritis between months 6 and 12. Thus, 19 eyes were clinically stable enough to evaluate the durability of the outcome across 6 and 12 months. No reclassification of outcome based on visual acuity occurred between 6 and 12 months, and no eye improved by more than 1 line on the Snellen chart. Only 1 of 19 eyes (5.3%) improved to be reclassified based on the Pelli-Robson contrast sensitivity chart between 6 and 12 months. Visual stability between 6 and 12 months was also observed in the Optic Neuritis Treatment Trial. [21] [22] [23] Thus, the 6-month outcome was used to allow inclusion of data from all 31 optic nerves and to avoid potential inconsistencies from recurrent optic neuritis. The 12-month data were used for those without recurrent optic neuritis to illustrate the longitudinal changes over the year.
MRI PROTOCOL AND REGION-OF-INTEREST ANALYSIS
The optic nerve imaging protocol and analysis have been previously published. 16 A 4-element surface receiver coil was used with a single-shot, spin-echo, echo planar imaging sequence and a 3-T MRI scanner (Allegra; Siemens AG, Munich, Germany). Eight averages utilized 12 diffusion encoding directions (b=600 s/mm 2 ) and a 1.3ϫ1.3ϫ1.3-mm 3 isotropic voxel. The region of interest was manually selected on the b 0 image to include 15 to 20 consecutive voxels (9.75-13.0 mm in length, with a voxel output size of 0.65 mm 3 isotropic) within the nerve center, starting 12 to 15 voxels (about 8.0 mm) posterior to the retina. To ensure reliable DTI measurements, selected voxels had a signal-to-noise ratio of at least 32, as previously described elsewhere.
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CLINICAL MEASURES
Vision tests were measured by use of a 20-foot Snellen wall chart for visual acuity, a 5% contrast sensitivity chart in an illuminated cabinet at 3 m (Precision Vision, La Salle, IL), and a PelliRobson contrast sensitivity chart at 1 m (Metropia Ltd, Cambridge, England). Best-corrected vision was achieved with glasses or pinhole occluder. Pattern VEPs were obtained on either a Nicolet Viking Select system (CareFusion, San Diego, California) or a Diagnosys Espion system with 60-minute check size (Lowell, Massachusetts). P100 latency and N75:P100 amplitude were read in blinded fashion. If the waveform was unobtainable from inadequate vision, the maximal latency of 170 milliseconds and the minimal amplitude of 1.5 mV were used (occurring at follow-up for only 2 eyes within a single individual, at both 6 and 12 months). Optical coherence tomography RNFL thickness was obtained on a Zeiss Stratus OCT III with version 4.0 software (Hennigsdorf, Germany) by a trained and certified technician, using fast RNFL scan mode. Optical coherence tomography scans with a signal strength of less than 7 were excluded.
STATISTICS
All tests were 2-tailed, and models were checked for proper covariance structure (SAS Institute, Cary, North Carolina). Spearman correlation coefficients were used to express the relationship between DTI parameters, baseline clinical measures, and 6-month clinical measures. Generalized estimating equations were used to account for repeated longitudinal measures and clustered observations from 2 eyes within an individual. Linear regression models were used to determine the effect of DTI parameters on predicting contrast sensitivity outcome, while controlling for age, sex, use of intravenous glucocorticoids, and visual acuity at onset. Logistic regression models were used to evaluate the risk of not recovering to normal vision (ie, a visual acuity of Ն0.8 and a contrast sensitivity of Ͼ1.60 logMAR), while also controlling for baseline variables as in the linear models. Linear repeated-measures models were used to determine the time course of DTI alterations, along with 95% confidence intervals (CIs).
RESULTS
DEMOGRAPHICS
Twenty-five subjects, all of whom had at least 6 months of follow-up, contributed 31 acutely injured optic nerves ( Table 1) . Three subjects presented with simultaneous and bilateral optic neuritis, and another 3 subjects had sequential optic neuritis, with the onset of optic neuritis occurring in the second eye within 21 days of it occurring in the first eye. In all sequential cases, the second eye had been clinically and radiographically documented as normal at the time the first eye was affected. Fifteen subjects presented with clinically isolated syndrome (optic neuritis with an abnormal brain MRI consistent with demyelination), 5 had isolated optic neuritis (normal brain MRI and negative for neuromyelitis optica IgG antibodies), 1 developed chronic recurrent inflammatory optic neuritis (normal brain and spine MRI and negative for neuromyelitis optica IgG antibodies), and 1 had acute disseminated encephalomyelitis (also with encephalopathy and transverse myelitis, abnormal brain MRI at onset, negative for neuromyelitis optica IgG antibodies, normal brain MRI, and no relapse at 3.5-year follow-up). Three eyes of patients who presented with acute vision loss and an abnormal brain MRI were months later determined to have had nonarteritic ischemic optic neuropathy. Eyes with incomplete recovery from nonarteritic ischemic optic neuropathy did not differ in mean DTI parameters at onset from those with acute optic neuritis (fractional anisotropy [P = .77], mean diffusivity [P = .84], AD [P = .97], and radial diffusivity [P = .81]); analyses were performed with and without inclusion of subjects with nonarteritic ischemic optic neuropathy.
LOW BASELINE AD AS A PREDICTOR OF INCOMPLETE VISUAL RECOVERY AT 6 MONTHS
Baseline AD differentiated subjects with complete clinical recovery by 6 months ( . Odds of complete 6-month recovery decreased by 53% (95% CI, 27%-70%) for every 0.1-unit decrease in AD at baseline. When both baseline AD and visual acuity were included as covariates in a predictive model of 6-month recovery, AD continued to provide an independent prognostic value (P=.03). Additional covariates in the model for predicting outcome were not significant, including age (P=.58), sex (P = .68), and use of intravenous glucocorticoids (P =.39). After excluding the 3 subjects who were later diagnosed with nonarteritic ischemic optic neuropathy, we found that a low AD continued to predict 6-month incomplete recovery (odds ratio, 0.47 [95% CI, 0.18-0.65]; P = .03). Thus, AD was a predictor of outcome in subjects with inflammatory and demyelinating optic neuritis.
Affected eyes with incomplete recovery demonstrated a lower mean AD ( 
CORRELATION BETWEEN LOW BASELINE AD AND WORSE CLINICAL OUTCOME MEASURES AT 6 MONTHS
Baseline AD correlated with the 6-month visual acuity (r=0.40, P=.03), 5% contrast sensitivity (r=−0.45, P=.01), and Pelli-Robson contrast sensitivity (r = 0.41, P = .02) ( Table 2) . When evaluating only those cases of optic neuritis with moderate to severe onset (visual acuity, Յ0.5), we found that AD continued to correlate with the 6-month 5% contrast sensitivity (r=0.43, P=.05) and PelliRobson contrast sensitivity (r = 0.48, P = .03). In addition, lower values of baseline AD correlated with lower VEP amplitudes (r = 0.55, P Ͻ .01), thinner RNFLs (r=0.57, P=.02), and the prolongation of VEP latencies (r=−0.38, P=.04) at 6 months. Mean diffusivity demonstrated more variable correlations with 6-month clinical outcomes (Table 2) .
POOR VISUAL ACUITY AT ONSET AS A PREDICTOR OF WORSE RECOVERY
Visual acuity at onset was not predictive of visual acuity at 6 months (r=0.31, P=.94). In the aggregate, baseline visual acuity was a predictor of 6-month Pelli-Robson contrast sensitivity (r=0.43, P=.02), although for the 21 subjects with moderate to severe loss of vision at presentation (visual acuity, Յ0.5), visual acuity was not a predictor of Pelli-Robson contrast sensitivity (r=0.03, P=.91). For the entire group, visual acuity at baseline was not a predictor of 5% contrast sensitivity at 6 months (r=−0.16, P=.39).
CORRELATION BETWEEN LOW AD AND WORSE BASELINE CLINICAL MEASURES
Axial diffusivity at baseline had moderate correlations with baseline visual acuity (r=0.49, PϽ.01), 5% contrast sensitivity (r=−0.40, P=.02), and Pelli-Robson contrast sensitivity (r=0.50, PϽ.01) ( Table 2) . Mean diffusivity had similar baseline correlations (Table 2) .
TIME COURSE FOR LOW AD
Low AD was confined to the first month. Axial diffusivity for the group was 1.58 µm 2 /ms (95% CI, 1.50-1.66 µm 2 /ms) over the first month, increasing at 3 months to /ms] at 4 weeks) and progressively increased over the ensuing year (Figure 1) Abbreviations: AD, axial diffusivity; CS, contrast sensitivity; DTI, diffusion tensor imaging; FA, fractional anisotropy; MD, mean diffusivity; PRCS, Pelli-Robson contrast sensitivity; RD, radial diffusivity; RNFL, retinal nerve fiber layer; VA, visual acuity; VEP, visual evoked potential.
a Spearman rank correlation coefficients are used, and significant correlations are highlighted in bold. b Significance at P Ͻ.05 maintained after excluding nerves associated with nonarteritic ischemic optic neuropathy. Time course of changes in the parameters used in diffusion tensor imaging (DTI) of the optic nerves of subjects from onset of optic neuritis during a 1-year period. All cases are included (n=25). All parameters become altered by 3 months in comparison with the 0.5-month visit. Both radial diffusivity and mean diffusivity continue to increase between 3 and 12 months, whereas axial diffusivity and fractional anisotropy demonstrate a trend toward further alteration over the latter 9-month interval. The scale for fractional anisotropy on the lower y-axis is expanded to better illustrate the magnitude of change. The error bars indicate 95% confidence intervals.
lar to radial diffusivity, became clearly abnormal by month 3, and they continued to be altered through month 12 ( Figure 1 
COMMENTS
Our study establishes that low AD during the initial episode of optic neuritis is a predictor of incomplete visual recovery. Low AD at presentation was consistently associated with worse performance among 6-month clinical measures of vision, which included visual acuity, 5% contrast sensitivity, and Pelli-Robson contrast sensitivity. After accounting for baseline visual acuity and demographics, we found that AD provided a significant contribution to risk stratification. Furthermore, initial AD was associated with a smaller VEP amplitude and a thinner RNFL at 6 months, in addition to a prolonged VEP latency. Because it is not possible to obtain histopathologic data from acutely affected human optic nerves, the results from these ancillary tests, in the context of prior animal imaging and pathologic data, lend support to a relationship between low AD, more severe tissue damage, and axon injury in acute optic neuritis. In contrast, radial diffusivity and mean diffusivity were not significantly altered at baseline and did not consistently predict clinical outcomes. Data on radial diffusivity and fractional anisotropy did help us to differentiate outcomes in remote optic neuritis, 12 months later. 17 The optic nerve provides an opportunity to test DTI on a white matter tract with clear clinical end points. Optic neuritis is pertinent to MS, has a discreet clinical onset, and can result in significant disability. Studying the optic nerve with DTI is 1 step in a methodological approach to validate an imaging technique through animal models and human autopsy material with histopathologic correlation, and within different regions of the central nervous system, on a longitudinal and crosssectional basis. 24 Studying the optic nerve is part of a comprehensive approach to validate DTI for clinical trials and eventually clinical practice. Figure 2. Time course of changes in the parameters used in diffusion tensor imaging (DTI) of the optic nerves of subjects during a 1-year period, by recovery group. Axial diffusivity is more altered on the baseline DTI scan for those with incomplete visual recovery by 6 months. In contrast, radial diffusivity, fractional anisotropy, and mean diffusivity are not different on the baseline DTI scans per recovery group. However, by 12 months, radial diffusivity and fractional anisotropy are more altered between the complete and incomplete recovery groups, whereas axial diffusivity and mean diffusivity demonstrate overlapping 95% confidence intervals (error bars). Axial diffusivity continued to be a predictor of incomplete recovery after excluding nerves later diagnosed as nonarteritic ischemic optic neuropathy. Complete recovery was defined as a visual acuity of 0.8 or greater, based on the resolution adopted by the International Council of Ophthalmology, 19 and a contrast sensitivity of greater than 1.60 logMAR, based on the Pelli-Robson contrast sensitivity test.
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ARCH NEUROL / VOL 69 (NO. 1), JAN 2012 WWW.ARCHNEUROL.COM 69 A decreased mean diffusivity has previously been appreciated in acute MS lesions, but the cause remains unclear. [25] [26] [27] Decreased diffusion is typically seen in acute stroke, when ischemia is believed to result in membrane ion channel pump failure, intracellular sodium accumulation, and cytotoxic edema. 28 Acute demyelinating lesions are not typically associated with cytotoxic edema but with vasogenic edema and increased mean diffusivity. 29, 30 Thus, the low AD in our study is unlikely to be due to acute optic nerve swelling from vasogenic edema. In our study, the decrease in AD was no longer evident past 1 month from clinical onset. This may reflect that, as macrophages and other inflammatory cells infiltrate the tissue and clear myelin debris, the axons comprise a smaller proportion of the tissue, lessening their contribution to diffusivity. Although normal at baseline, radial diffusivity increased steeply over the next 1 to 3 months, perhaps indicating continued demyelination with myelin debris clearance. 31 Within acute MS lesions, early metabolic derangements may result in failure of ion channels and transport mechanisms in axons. Organelle and protein accumulation may lead to increased intra-axonal viscosity and axonal swelling, contributing to a decrease in AD. Compromised axonal transport in acute axonal injury has been previously demonstrated by the accumulation of the ␤-amyloid precursor protein. Some reports [32] [33] [34] [35] of MS tissue qualitatively describe swollen or beaded axons on the longitudinal or the oblique section, and such structural alterations may contribute to alterations of AD in the acute setting.
Other longitudinal studies 36, 37 have investigated quantitative imaging in acute optic neuritis. In contrast to DTI, the magnetization transfer ratio of the optic nerve was normal during acute optic neuritis and progressively decreased over the next 8 months. 36 Recovery of the magnetization transfer ratio during the last third of the first year correlated with visual recovery, emphasizing the role of complementary quantitative imaging. Another study 37 demonstrated increased optic nerve volume at onset through 3 months, although neither optic nerve swelling nor atrophy was associated with visual outcome.
A prior study 38 of DTI within acute enhancing brain lesions found no relationship between low AD and risk for chronic T1 hypointensity (a surrogate for axonal loss). In our study, DTI was focused on a directional and compact white matter tract. Although the brain does contain well-organized white matter tracts, lesions also occur within regions of low anisotropy and crossing fibers. Thus, studying AD changes in the brain may require a method capable of resolving multiple tensors to elucidate crossing fibers and to separate the axonal and demyelinating components from edema, cellular infiltration, and widening interstitial spaces. 39 In contrast to radial diffusivity and mean diffusivity in the optic nerve, radial diffusivity and mean diffusivity in the brain may hold more potential within both acute and chronic lesions. 38 Understanding the dynamics of DTI changes in response to injury within different regions of the central nervous system may assist in further assessments of prognosis and treatment.
Diffusion tensor imaging of the optic nerve could be used in multicenter clinical studies with special provisions. It might also be used in the future to stratify risk for incomplete recovery and to identify subjects who may benefit from an early therapeutic intervention. Obtaining high-resolution 1.3-mm isotropic voxels permits the inclusion of the optic nerve center, and optimal signal is achieved by a surface coil, 3-T MRI scanner, and multiple averages. Care in preparing and positioning the patient, along with an imaging session dedicated only to optic nerve imaging, will ensure minimal movement during the 40-minute sequence.
Diffusion tensor imaging provides a noninvasive means to quantify tissue changes on a longitudinal basis in the human central nervous system, a region in which serial histological evaluations are not feasible. Multiple sclerosis lesions display varying combinations of axonal injury, demyelination, and inflammation with diverse inflammatory cell populations, all of which change over time. In addition, severe demyelination may lead to chronic loss of function indistinguishable from axonal injury; all disability in MS may not be attributable to a single pathologic process. Diffusion tensor imaging may provide a more specific window into the pathology of MS, which is recognized to be heterogeneous, complex, and dynamic. Future studies of directional diffusivities in the brain and spinal cord are planned to further elucidate the relationship between tissue integrity, MS lesion evolution, and clinical outcomes. 
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